Kyongbo Pharmaceutical Co Ltd (214390) — Working Capital to Net Assets Ratio
Kyongbo Pharmaceutical Co Ltd (214390) has a Working Capital to Net Assets ratio of -16.1% as of June 2026. Working capital of ₩-23.65 Billion (current assets of ₩169.90 Billion minus current liabilities of ₩193.55 Billion) is measured against net assets of ₩146.99 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 214390 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Kyongbo Pharmaceutical Co Ltd Working Capital to Net Assets (2014–2025)
This chart shows how Kyongbo Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at -16.1%, reflecting working capital of ₩-23.65 Billion against net assets of ₩146.99 Billion KRW. For the complete balance sheet picture, see how large is Kyongbo Pharmaceutical Co Ltd's balance sheet.
Annual Working Capital to Net Assets for Kyongbo Pharmaceutical Co Ltd (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Kyongbo Pharmaceutical Co Ltd from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check 214390 financial resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 8.2% | ₩11.89 Billion | ₩145.74 Billion | ₩159.14 Billion | ₩147.25 Billion | ▼ -5.0 pp |
| 2024 | 13.2% | ₩19.28 Billion | ₩146.15 Billion | ₩151.94 Billion | ₩132.66 Billion | ▲ +1.0 pp |
| 2023 | 12.2% | ₩17.64 Billion | ₩144.38 Billion | ₩135.90 Billion | ₩118.26 Billion | ▼ -2.2 pp |
| 2022 | 14.4% | ₩20.76 Billion | ₩143.70 Billion | ₩116.33 Billion | ₩95.57 Billion | ▼ -0.9 pp |
| 2021 | 15.3% | ₩22.35 Billion | ₩145.70 Billion | ₩111.17 Billion | ₩88.81 Billion | ▼ -13.1 pp |
| 2020 | 28.5% | ₩44.43 Billion | ₩156.06 Billion | ₩138.19 Billion | ₩93.76 Billion | ▲ +1.4 pp |
| 2019 | 27.1% | ₩40.36 Billion | ₩149.16 Billion | ₩124.18 Billion | ₩83.81 Billion | ▼ -13.0 pp |
| 2018 | 40.0% | ₩59.62 Billion | ₩149.01 Billion | ₩128.94 Billion | ₩69.32 Billion | ▲ +4.5 pp |
| 2017 | 35.5% | ₩50.26 Billion | ₩141.51 Billion | ₩110.64 Billion | ₩60.38 Billion | ▲ +12.7 pp |
| 2016 | 22.8% | ₩29.51 Billion | ₩129.40 Billion | ₩102.23 Billion | ₩72.72 Billion | ▼ -10.2 pp |
| 2015 | 33.0% | ₩40.57 Billion | ₩122.82 Billion | ₩105.11 Billion | ₩64.54 Billion | ▲ +15.7 pp |
| 2014 | 17.4% | ₩11.86 Billion | ₩68.33 Billion | ₩97.48 Billion | ₩85.62 Billion | — |